awmsg logo



epoetin zeta (Retacrit®)


Reference No. 1226

Publication date:
06/01/2012


Appraisal information

epoetin zeta (Retacrit®) solution for injection


Company: Hospira UK Ltd
BNF category: Nutrition and blood
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 20/12/2011

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, epoetin zeta (Retacrit®) cannot be endorsed for use within NHS Wales for the reduction of exposure to allogeneic blood transfusions in adult non-iron deficient patients prior to major elective orthopaedic surgery, having a high perceived risk for transfusion complications.
Statement of Advice (SOA)
Download